Cprx earnings forecast
WebMay 13, 2024 · Statutory earnings per share are expected to nosedive 45% to US$0.38 in the same period. In the lead-up to this report, the analysts had been modelling revenues of US$134.5m and earnings per share ... WebApr 14, 2024 · CPRX has returned 22.4% in the past month. For Catalyst , the consensus EPS estimate for the upcoming report has changed +9.4% over the past month to $0.30. This represents a change of +150% from ...
Cprx earnings forecast
Did you know?
Web2 hours ago · CPRX has returned 22.4% in the past month. For Catalyst , the consensus EPS estimate for the upcoming report has changed +9.4% over the past month to $0.30. … WebStock Price Forecast The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 22.00, with a high estimate of 25.00 and a …
WebApr 12, 2024 · The Catalyst Pharmaceuticals stock price gained 2.66% on the last trading day (Thursday, 6th Apr 2024), rising from $16.93 to $17.38. During the last trading … WebFeb 14, 2024 · 355 Alhambra Circle. Suite 801. Coral Gables, Florida 33134. Phone 1 305 420-3200. Industry Pharmaceuticals. Sector Health Care/Life Sciences. Fiscal Year-end 12/2024. Revenue $140.83M.
Web19 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Catalyst Pharmaceuticals (CPRX) WebApr 11, 2024 · Catalyst Pharmaceuticals, Inc. (CPRX) latest earnings report: revenue, EPS, surprise, history, news and analysis.
WebApr 3, 2024 · Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Get Rating) - Research analysts at Zacks Research issued their Q1 2024 earnings per share estimates for Catalyst Pharmaceuticals in a note issued to investors on Wednesday, March 29th. Zacks Research analyst S. Ganoria forecasts that the biopharmaceutical company will post earnings per …
WebApr 8, 2024 · Catalyst Pharmaceuticals (NASDAQ:CPRX) has a market capitalization of $1.84 billion and generates $214.20 million in revenue each year. The … business wrapsWebApr 1, 2024 · NASDAQ CPRX opened at $16.58 on Friday. The firm has a market capitalization of $1.75 billion, a P/E ratio of 22.41 and a beta of 1.16. Catalyst Pharmaceuticals has a 1-year low of $6.15 and a 1 ... cbs sports printable ncaa bracket 2021WebNov 15, 2024 · NasdaqCM:CPRX Earnings and Revenue Growth November 15th 2024 There was no particular change to the consensus price target of US$7.40, with Catalyst Pharmaceuticals' latest outlook seemingly not ... business write off carsWebApr 10, 2024 · CPRX’s price/forward earnings is 23.01. Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper ... cbs sports playoffsWebMar 23, 2024 · CPRX stock opened at $16.21 on Wednesday. The firm has a 50 day moving average of $16.22 and a 200 day moving average of $15.66. The stock has a market capitalization of $1.71 billion, a PE ratio ... business write offs 2016WebNov 9, 2024 · Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.10 per share a year ago. business write off mortgageWebCatalyst Pharma (CPRX) is an absolute monster. Not only is the company posting huge sales and earnings growth in a sector that rarely has either, the stock has more than doubled over the last few months. There are 801 stocks in the biotech group tracked by Investors Business Daily, and CPRX ranks at the very top (see image in chart). business write off checklist